Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia

Código QR

Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia

Valeria Pereira de Sousa,1 Joanne Crean,2 Vinícius Raphael de Almeida Borges,1 Carlos Rangel Rodrigues,1 Lidia Tajber,2 Fabio Boylan,2 Lucio Mendes Cabral1 1Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 2School of Pharmacy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	de Sousa VP, Crean J, Borges VRA, Rodrigues CR, Tajber L, Boylan F, Cabral LM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/196547c89b6b41c181b19d009e887fc1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Carbon-dots from babassu coconut (Orbignya speciosa) biomass: Synthesis, characterization, and toxicity to Daphnia magna
por: Rubens S. Costa, et al.
Publicado: (2021)

Chemical constituent analysis of the Babassu (Orbignya phalerata Mart.) mesocarp
por: Gabriela Batista de Farias, Jean Lucas da Silva Rodrigues, Jean Lucas da Silva Rodrigues, Lyege Oliveira Magalhães, Antonio Gilberto Ferreira, Maria da Paz Lima
Publicado: (2019)

Physicochemical and nutritional aspects of babassu coconut almond and oil (Orbignya phalerata Mart.)
por: Costa,Ana, et al.
Publicado: (2020)

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
por: D Gnyawali, et al.
Publicado: (2016)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida M, et al.
Publicado: (2011)

High regional variation in prostate surgery for benign prostatic hyperplasia in Switzerland.
por: Maria M Wertli, et al.
Publicado: (2021)

Postoperative complications in patients with benign prostatic hyperplasia according to surgical technique
por: Luis Felipe Pérez Medina, et al.
Publicado: (2021)

Postoperative complications in patients with benign prostatic hyperplasia according to surgical technique
por: Luis Felipe Pérez Medina, et al.
Publicado: (2021)

Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Diaa-Eldin Taha, et al.
Publicado: (2018)

A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia
por: Kristian Leisegang, et al.
Publicado: (2022)

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
por: Deli Liu, et al.
Publicado: (2020)

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
por: Al-Trad B, et al.
Publicado: (2019)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
por: Lee WC, et al.
Publicado: (2013)

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Michael A. Kiebish, et al.
Publicado: (2021)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013)

Bipolar Transurethral Enucleation of the Prostate: Is it a size-independent endoscopic treatment option for symptomatic benign prostatic hyperplasia?
por: Carolina Bebi, et al.
Publicado: (2021)

Influence of р-thyrozol on the morphology and antioxidant-prooxidant balance in prostate of rats at sulpiride-induced benign prostatic hyperplasia
por: T. G. Borovskaya, et al.
Publicado: (2014)

Incidence and Risk Factors of Post-Operative Depression in Patients Undergoing Transurethral Resection of Prostate for Benign Prostatic Hyperplasia
por: Zhu D, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Jinze Li, et al.
Publicado: (2021)

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
por: Giorgio Ivan Russo, et al.
Publicado: (2021)

Urinary Tract Stones Risk Factors in Patients with Benign Prostatic Hyperplasia in West Java, Indonesia
por: Iman Surendroputro Tjahjodjati, et al.
Publicado: (2021)

Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study.
por: Hasniza Zaman Huri, et al.
Publicado: (2014)

High Concentration of Reticular Fibers in Periurethral Region of the Prostatic Urethra from Patients with Benign Prostatic Hyperplasia as Revealed by Stereology
por: Manaia,Jorge H. M, et al.
Publicado: (2012)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
por: Grzesiak K, et al.
Publicado: (2018)

Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
por: Bianka Darvalics
Publicado: (2020)

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
por: Julius Gudmundsson, et al.
Publicado: (2018)

Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
por: McNicholas TA
Publicado: (2016)

Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use
por: Soares da Silva LFJ, et al.
Publicado: (2011)

The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
por: Yang L, et al.
Publicado: (2021)

Simultaneous antegrade and retrograde endoscopic surgery for benign prostatic hyperplasia with vesical calculi – A single-centre experience
por: Tarun Javali, et al.
Publicado: (2018)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Claus G Roehrborn, et al.
Publicado: (2008)

Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
por: Wang XY, et al.
Publicado: (2016)

Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation of the prostate in high-risk patients with benign prostatic hyperplasia and coronary artery disease
por: Qingchao Meng, et al.
Publicado: (2021)

The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis
por: Shaun Wen Huey Lee, et al.
Publicado: (2017)

Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
por: Zhu LL, et al.
Publicado: (2015)

Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation
por: Borges VRA, et al.
Publicado: (2013)

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
por: McVary KT, et al.
Publicado: (2021)

Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
por: Magdalena Hagovska, et al.
Publicado: (2021)

Increased risk of subsequent benign prostatic hyperplasia in non-Helicobacter pylori-infected peptic ulcer patients: a population-based cohort study
por: Chu-Wen Fang, et al.
Publicado: (2020)